Post Profile






Researchers map brain tumor cells' adaptation to oxygen deprivation

(Lund University) The most aggressive variant of brain tumor -- glioblastoma -- has an average survival rate of 15 months. There is therefore an urgent need for new treatment strategies for this group of patients. A research team from Lund University in Sweden has now identified new factors which may affect the tumor cells' ability to resist treatment. The study has been published in Cell Reports.
read more

share

Related Posts


Penn's Glowing Cancer Tool Illuminates Benign, but Dangerous, Brain Tumors during Pituitary Surgery

Health : Newswise Medical News

An experimental imaging tool that uses a targeted fluorescent dye successfully lit up the benign brain tumors of patients during removal surgery, allowing surgeons to identify tumor tissue, a new study from researchers at the Perelm...

Moffitt Cancer Center Researchers Identify Protein Pathway Involved in Brain Tumor Stem Cell Growth

Health : Newswise Medical News

Glioblastomas are a highly aggressive type of brain tumor, with few effective treatment options. Moffitt Cancer Center researchers are one step closer to understanding glioblastoma development following the identification of a key p...

Zika virus kills brain cancer stem cells

Health : EurekAlert: Health

(Washington University School of Medicine) While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. New research from W...

Zika Virus Kills Brain Cancer Stem Cells

Health : Newswise Medical News

While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. New research from Washington University School of Medicine in ...

Moffitt Cancer Center Researchers Target Specific Protein Associated with Poor Survival and Treatment Resistance in Brain Cancer Patients

Health : Newswise Medical News

TAMPA, Fla. - Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with low survival rates, with newly diagnosed patients surviving a median of 14 months and recurrent patients surviving a median of only 3 to 9 months. N...

Comments


Copyright © 2016 Regator, LLC